211 related articles for article (PubMed ID: 32310173)
1. Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia.
Sun Y; Tan L; Xu W; Wang ZT; Hu H; Li JQ; Dong Q; Tan L; Yu JT;
J Alzheimers Dis; 2020; 75(3):729-737. PubMed ID: 32310173
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
3. Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.
Qu Y; Tan CC; Shen XN; Li HQ; Cui M; Tan L; Dong Q; Yu JT;
Stroke; 2021 Mar; 52(3):896-904. PubMed ID: 33517704
[TBL] [Abstract][Full Text] [Related]
4. The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
Neurobiol Aging; 2021 Jan; 97():10-17. PubMed ID: 33070094
[TBL] [Abstract][Full Text] [Related]
5. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
7. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma neurofilament light chain with cognition and neuroimaging measures in community-dwelling early old age men.
Tang R; Buchholz E; Dale AM; Rissman RA; Fennema-Notestine C; Gillespie NA; Hagler DJ; Lyons MJ; Neale MC; Panizzon MS; Puckett OK; Reynolds CA; Franz CE; Kremen WS; Elman JA
Alzheimers Res Ther; 2024 Apr; 16(1):90. PubMed ID: 38664843
[TBL] [Abstract][Full Text] [Related]
9. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament light protein in blood predicts regional atrophy in Huntington disease.
Johnson EB; Byrne LM; Gregory S; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RA; Zetterberg H; Tabrizi SJ; Scahill RI; Wild EJ;
Neurology; 2018 Feb; 90(8):e717-e723. PubMed ID: 29367444
[TBL] [Abstract][Full Text] [Related]
11. Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease.
Chong JR; Hilal S; Ashton NJ; Karikari TK; Reilhac A; Vrooman H; Schöll M; Zetterberg H; Blennow K; Chen CP; Lai MKP
Alzheimers Dement (Amst); 2023; 15(1):e12396. PubMed ID: 36994314
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
[TBL] [Abstract][Full Text] [Related]
13. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J
Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults.
Hu H; Chen KL; Ou YN; Cao XP; Chen SD; Cui M; Dong Q; Tan L; Yu JT;
Aging (Albany NY); 2019 Sep; 11(17):6904-6914. PubMed ID: 31514172
[TBL] [Abstract][Full Text] [Related]
16. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults: The Cardiovascular Health Study.
Fohner AE; Bartz TM; Tracy RP; Adams HHH; Bis JC; Djousse L; Satizabal CL; Lopez OL; Seshadri S; Mukamal KJ; Kuller LH; Psaty BM; Longstreth WT
Neurology; 2022 Mar; 98(9):e903-e911. PubMed ID: 34921102
[TBL] [Abstract][Full Text] [Related]
18. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
[TBL] [Abstract][Full Text] [Related]
19. Atypical White Matter Hyperintensities Markedly Impact Plasma Neurofilament Light Chain Variability in GRN Patients.
Vítor J; Saracino D; Ströer S; Camuzat A; Dorgham K; Clot F; Martin-Hardy P; Pasquier F; ; Le Ber I
J Alzheimers Dis; 2023; 94(4):1351-1360. PubMed ID: 37393503
[TBL] [Abstract][Full Text] [Related]
20. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]